Oliver Sol
Chief Tech/Sci/R&D Officer bij AC IMMUNE SA
Profiel
Oliver Sol is currently working as the VP & Head-Clinical Development at AC Immune SA. Previously, he worked as the Clinical Director at Exonhit and as the Director-Medical & Regulatory Affairs at Eurobio-Scientific SA. Dr. Sol holds a doctorate degree from Université de Paris XI Paris Sud.
Actieve functies van Oliver Sol
| Bedrijven | Functie | Begin |
|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Oliver Sol
| Bedrijven | Functie | Einde |
|---|---|---|
| EUROBIO SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Oliver Sol
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AC IMMUNE SA | Health Technology |
| EUROBIO SCIENTIFIC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
